We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPAM icon
776
EPAM Systems
EPAM
$5.25B
– –
-1,397
Closed -$211K
ESI icon
777
Element Solutions
ESI
$8.89B
– –
-12,121
Closed -$305K
ESTA icon
778
Establishment Labs
ESTA
$2.7B
– –
-4,948
Closed -$203K
ETNB
779
DELISTED
89bio
ETNB
– –
-15,124
Closed -$222K
ETON icon
780
Eton Pharmaceutcials
ETON
$1.28B
– –
-10,535
Closed -$229K
EVER icon
781
EverQuote
EVER
$960M
– –
-9,158
Closed -$209K
EVTL icon
782
Vertical Aerospace
EVTL
$172M
– –
-56,565
Closed -$294K
EW icon
783
Edwards Lifesciences
EW
$48.2B
– –
-2,779
Closed -$216K
EWBC icon
784
East-West Bancorp
EWBC
$18B
– –
-2,449
Closed -$261K
FC icon
785
Franklin Covey
FC
$248M
– –
-21,197
Closed -$411K
FF icon
786
Future Fuel
FF
$202M
– –
-18,964
Closed -$73.6K
FIZZ icon
787
National Beverage
FIZZ
$3.05B
– –
-5,882
Closed -$217K
FLNC icon
788
Fluence Energy
FLNC
$1.68B
– –
-34,897
Closed -$377K
FLWS icon
789
1-800-Flowers.com
FLWS
$254M
– –
-34,044
Closed -$157K
FMX icon
790
Fomento Económico Mexicano
FMX
$43.5B
– –
-2,093
Closed -$206K
FOLD
791
DELISTED
Amicus Therapeutics
FOLD
– –
-11,998
Closed -$94.5K
FOUR icon
792
Shift4
FOUR
$4.35B
– –
-3,035
Closed -$235K
FRSH icon
793
Freshworks
FRSH
$3.09B
– –
-23,135
Closed -$272K
FRT icon
794
Federal Realty Investment Trust
FRT
$10.9B
– –
-2,260
Closed -$229K
FSBC icon
795
Five Star Bancorp
FSBC
$1.02B
– –
-7,477
Closed -$241K
FTDR icon
796
Frontdoor
FTDR
$5.22B
– –
-5,400
Closed -$363K
FTI icon
797
TechnipFMC
FTI
$28.9B
– –
-11,483
Closed -$453K
FTK icon
798
Flotek Industries
FTK
$856M
– –
-21,545
Closed -$315K
FTNT icon
799
Fortinet
FTNT
$110B
– –
-2,397
Closed -$202K
FTRE icon
800
Fortrea Holdings
FTRE
$1.96B
– –
-16,792
Closed -$141K
30 31
32
33 34

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.